Roberto Vieira

Roberto Vieira is currently the President of Oncology at Corcept Therapeutics, a position held since January 2024. Previously, Roberto served as Senior Vice President of US Commercial at Mirati Therapeutics, where the focus included leading the launch of the company's first product in the US market. Prior to Mirati, Roberto held various leadership roles at Bristol-Myers Squibb from January 2005 to January 2020, including Vice President of Worldwide Oncology Strategy, overseeing portfolio and disease strategy, and Executive Director roles in both oncology and virology divisions. Roberto's earlier experience includes product management roles at Eli Lilly do Brasil and Eli Lilly in the United States. Roberto Vieira holds an MBA from the University of Pittsburgh and completed a General Management Program at CEDEP/INSEAD.